Public court records · Regulatory sources · Independently maintained Data as of: 2026-10-21 · Not legal advice

Roundup (Glyphosate) Lymphoma (US): Settlement Amounts

settlement

United States case record · Last verified:

Reported amounts & case results

Bayer has paid over $11 billion in total (per public reports), including a $7.25 billion settlement covering current and future claims (per court, Mar 2026). The settlement covers non-Hodgkin lymphoma claims only, with tiered compensation by exposure, age and NHL type: per the settlement terms as discussed at the Sep 14, 2026 fairness hearing, an occupational user diagnosed with an aggressive NHL under age 60 could see a payout of $165,000 on average, with individual awards varying from 80% to 120% (per The New Lede). Final approval is still pending as of the Oct 21 2026 check: the official settlement site (updated Sep 21 2026) says registration and claim submission are unavailable until the court grants final approval, and Bayer had asked for a delay in the decision (per public reports, Oct 2026). No outcome can be promised.

Figures are as reported by the cited sources — not a promise of any individual outcome.

Reported amounts are what sources say — not a promise. Individual results depend on injuries, jurisdiction, and the stage of the case. This is not legal advice.

What affects case value

  • Injury severity — the single largest driver across mass torts.
  • Jurisdiction — national/state/provincial law (e.g., discovery rules, statute of limitations) can change outcomes.
  • Case stage — early filings and post-bellwether values differ.
  • Documentation — medical records and the exposure timeline.

Estimate your situation

See whether your case compares to documented outcomes. Free, no obligation.

Start free case review →